JP2022505022A5 - - Google Patents
Info
- Publication number
- JP2022505022A5 JP2022505022A5 JP2021518633A JP2021518633A JP2022505022A5 JP 2022505022 A5 JP2022505022 A5 JP 2022505022A5 JP 2021518633 A JP2021518633 A JP 2021518633A JP 2021518633 A JP2021518633 A JP 2021518633A JP 2022505022 A5 JP2022505022 A5 JP 2022505022A5
- Authority
- JP
- Japan
- Prior art keywords
- substance
- pharmaceutical
- alpha
- substance used
- emitting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024174991A JP2025013822A (ja) | 2018-11-01 | 2024-10-04 | 腫瘍内アルファ放射体放射と細胞内病原体に対する細胞質プラズマセンサーの活性化 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862753930P | 2018-11-01 | 2018-11-01 | |
| US62/753,930 | 2018-11-01 | ||
| PCT/IB2019/059331 WO2020089819A1 (en) | 2018-11-01 | 2019-10-31 | Intratumoral alpha-emitter radiation and activation of cytoplasmatic sensors for intracellular pathogen |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024174991A Division JP2025013822A (ja) | 2018-11-01 | 2024-10-04 | 腫瘍内アルファ放射体放射と細胞内病原体に対する細胞質プラズマセンサーの活性化 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022505022A JP2022505022A (ja) | 2022-01-14 |
| JP2022505022A5 true JP2022505022A5 (cg-RX-API-DMAC7.html) | 2022-10-19 |
Family
ID=70464034
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021518633A Pending JP2022505022A (ja) | 2018-11-01 | 2019-10-31 | 腫瘍内アルファ放射体放射と細胞内病原体に対する細胞質プラズマセンサーの活性化 |
| JP2024174991A Pending JP2025013822A (ja) | 2018-11-01 | 2024-10-04 | 腫瘍内アルファ放射体放射と細胞内病原体に対する細胞質プラズマセンサーの活性化 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024174991A Pending JP2025013822A (ja) | 2018-11-01 | 2024-10-04 | 腫瘍内アルファ放射体放射と細胞内病原体に対する細胞質プラズマセンサーの活性化 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US12594291B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3873598B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2022505022A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210087949A (cg-RX-API-DMAC7.html) |
| CN (2) | CN117338800A (cg-RX-API-DMAC7.html) |
| AU (3) | AU2019370892B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3114299A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3035872T3 (cg-RX-API-DMAC7.html) |
| HR (1) | HRP20250846T1 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE072799T2 (cg-RX-API-DMAC7.html) |
| PL (1) | PL3873598T3 (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202102627PA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020089819A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10350431B2 (en) | 2011-04-28 | 2019-07-16 | Gt Medical Technologies, Inc. | Customizable radioactive carriers and loading system |
| US9821174B1 (en) | 2015-02-06 | 2017-11-21 | Gammatile Llc | Radioactive implant planning system and placement guide system |
| US10888710B1 (en) | 2016-11-29 | 2021-01-12 | Gt Medical Technologies, Inc. | Transparent loading apparatus |
| CN116171152A (zh) * | 2020-09-15 | 2023-05-26 | 昂科因凡特公司 | 制备的镭-224和子代联合dna修复抑制剂,用于放射性核素治疗 |
| IL303002B1 (en) | 2020-12-16 | 2026-08-01 | Alpha Tau Medical Ltd | Radiation therapy using scattered alpha emitters with enhanced beta therapy |
| CN113230400A (zh) * | 2021-03-11 | 2021-08-10 | 上海交通大学 | 一种基于表观遗传调控的金纳米团簇放疗增敏组装体及其制备和应用 |
| CA3211766A1 (en) | 2021-03-19 | 2022-09-22 | Gt Medical Technologies, Inc. | Custom brachytherapy carriers |
| US12076583B2 (en) | 2021-06-10 | 2024-09-03 | Alpha Tau Medical Ltd. | Diffusing alpha-emitter radiation therapy for melanoma |
| US20220395702A1 (en) * | 2021-06-10 | 2022-12-15 | Alpha Tau Medical Ltd. | Diffusing alpha-emitter radiation therapy for glioblastoma |
| US20220395701A1 (en) * | 2021-06-10 | 2022-12-15 | Alpha Tau Medical Ltd. | Diffusing alpha-emitter radiation therapy for pancreatic cancer |
| US12042668B2 (en) | 2021-06-10 | 2024-07-23 | Alpha Tau Medical Ltd. | Diffusing alpha-emitter radiation therapy for squamous cell carcinoma |
| US12064643B2 (en) | 2021-06-10 | 2024-08-20 | Alpha Tau Medical Ltd. | Diffusing alpha-emitter radiation therapy for breast cancer |
| US20220395703A1 (en) * | 2021-06-10 | 2022-12-15 | Alpha Tau Medical Ltd. | Activity levels for diffusing alpha-emitter radiation therapy |
| US11964168B2 (en) | 2021-06-10 | 2024-04-23 | Alpha Tau Medical Ltd. | Diffusing alpha-emitter radiation therapy for prostate cancer |
| US12076582B2 (en) | 2021-06-10 | 2024-09-03 | Alpha Tau Medical Ltd. | Diffusing alpha-emitter radiation therapy for colorectal cancer |
| US12076581B2 (en) | 2021-06-10 | 2024-09-03 | Alpha Tau Medical Ltd. | Diffusing alpha-emitter radiation therapy for glioblastoma |
| US12070620B2 (en) | 2021-06-10 | 2024-08-27 | Alpha Tau Medical Ltd. | Activity levels for diffusing alpha-emitter radiation therapy |
| US12070621B2 (en) | 2021-06-10 | 2024-08-27 | Alpha Tau Medical Ltd. | Diffusing alpha-emitter radiation therapy for pancreatic cancer |
| JP2024521529A (ja) * | 2021-06-20 | 2024-05-31 | アルファ タウ メディカル リミテッド | 免疫チェックポイント調節因子と組み合わせた腫瘍内アルファ放射体照射 |
| EP4359071A4 (en) * | 2021-06-20 | 2026-04-22 | Alpha Tau Medical Ltd | Intratumoral Alpha Emitter Radiation in Combination with Vascular System Inhibitors |
| US12053644B2 (en) | 2021-12-30 | 2024-08-06 | Gt Medical Technologies, Inc. | Radiation shielding apparatus for implantable radioactive seeds |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000006243A2 (en) | 1998-07-28 | 2000-02-10 | Innerdyne, Inc. | Absorbable brachytherapy and chemotherapy delivery devices and methods |
| CA2398678A1 (en) | 2000-01-31 | 2001-08-09 | Yissum Research Development Company Of The Hebrew University In Jerusalem | Selective killing of cells by activation of double-stranded rna dependent protein kinase-pkr |
| US20030153083A1 (en) | 2000-01-31 | 2003-08-14 | Alexei Shir | Selective killing of cells by activation of double-stranded rna dependent protein kniase-pkr |
| GB0011903D0 (en) | 2000-05-18 | 2000-07-05 | Astrazeneca Ab | Combination chemotherapy |
| AU7548901A (en) * | 2000-06-16 | 2002-01-02 | Sloan Kettering Inst Cancer | Liposomal encapsulation of chelated actinium-225 and uses thereof |
| RU2284818C2 (ru) | 2001-05-10 | 2006-10-10 | Анормед, Инк. | Комбинированная химиотерапия |
| JP2005530734A (ja) * | 2002-04-15 | 2005-10-13 | スローン − ケッタリング インスティチュート フォー キャンサー リサーチ | 癌の処置のための併用療法 |
| WO2004045491A2 (en) | 2002-11-18 | 2004-06-03 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Targeted double stranded rna mediated cell killing |
| ATE424221T1 (de) | 2003-04-30 | 2009-03-15 | Univ Ramot | Verfahren und vorrichtung für strahlentherapie |
| US20050013812A1 (en) | 2003-07-14 | 2005-01-20 | Dow Steven W. | Vaccines using pattern recognition receptor-ligand:lipid complexes |
| GB0423565D0 (en) | 2004-10-22 | 2004-11-24 | Algeta As | Formulation |
| US7834064B2 (en) | 2005-01-03 | 2010-11-16 | Andres Mario Salazar | Clinical method for the immunomodulatory and vaccine adjuvant use of poly-ICLC and other dsRNAs |
| HUE037796T2 (hu) | 2005-07-26 | 2018-09-28 | Aplha Tau Medical Ltd | Radioaktív felületi forrás és eljárás elõállítására |
| CN101091794A (zh) * | 2006-06-19 | 2007-12-26 | 博尔诚(北京)科技有限公司 | 用于预防和治疗转移性肿瘤的组合物 |
| US20080124366A1 (en) | 2006-08-06 | 2008-05-29 | Ohlfest John R | Methods and Compositions for Treating Tumors |
| US20090088401A1 (en) | 2007-09-27 | 2009-04-02 | Andres Salazar | In-situ cancer autovaccination with intratumoral stabilized dsRNA viral mimic |
| US20110038888A1 (en) | 2008-01-10 | 2011-02-17 | Peter Emtage | Adjuvant compositions comprising poly-ic and a cationic polymer |
| US20090234628A1 (en) * | 2008-03-14 | 2009-09-17 | Siemens Medical Solutions Usa, Inc. | Prediction of complete response given treatment data |
| US20100015042A1 (en) * | 2008-07-03 | 2010-01-21 | Ramot At Tel Aviv University Ltd. | Combine radiation therapy and chemotherapy for treating cancer |
| US8821364B2 (en) | 2008-09-02 | 2014-09-02 | Battelle Memorial Institute | Brachytherapy seed with fast dissolving matrix for optimal delivery of radionuclides to cancer tissue |
| PT3098239T (pt) | 2008-12-22 | 2020-01-15 | Targimmune Therapeutics Ag | Vetor de rna de cadeia dupla dirigido ao egfr para o tratamento sistémico de cancro |
| US9642817B2 (en) | 2009-08-27 | 2017-05-09 | Technion Research & Development Foundation Limited | Liposomal compositions and uses of same |
| WO2011046934A1 (en) * | 2009-10-12 | 2011-04-21 | Au Jessie L-S | Methods and compositions for improved delivery, expression or activity of rna interference agents |
| EP2525835A4 (en) * | 2010-01-18 | 2016-01-20 | Univ Texas | METHOD AND COMPOSITION FOR PARTICLE-CONTROLLED MEDICAMENTAL OUTPUT IN CANCER CELLS |
| TR201807294T4 (tr) * | 2010-06-22 | 2018-06-21 | Centre Nat Rech Scient | Nükleik asit konjugatları için endosomolitik ajanlar ile optimize edilmiş in vivo aktarım sistemi. |
| CN104411331B (zh) | 2012-01-13 | 2018-08-21 | 哈佛学院董事会 | 在结构聚合装置中tlr激动剂的控制传递 |
| US10421971B2 (en) | 2014-01-15 | 2019-09-24 | The University Of Chicago | Anti-tumor therapy |
| SG11201702401RA (en) * | 2014-10-14 | 2017-04-27 | Novartis Ag | Antibody molecules to pd-l1 and uses thereof |
| US20180214583A1 (en) * | 2015-08-12 | 2018-08-02 | Bayer Pharma Aktiengesellschaft | Pharmaceutical combination for the treatment of cancer |
| CN105031648A (zh) * | 2015-08-25 | 2015-11-11 | 徐州医学院 | 新型靶向纳米粒子及其制备方法和用途 |
| PT3319587T (pt) * | 2015-11-17 | 2019-11-20 | Bioncotech Therapeutics S L | Nova composição farmacêutica que compreende partículas compreendendo um complexo de um polirribonuleótido de cadeia dupla e uma polialquilenoimina |
| WO2017173101A1 (en) * | 2016-03-30 | 2017-10-05 | Virginia Commonwealth University | Combination therapy for neuroblastoma using mda-7/il-24 with therapeutic agents |
| US11633506B2 (en) * | 2016-07-18 | 2023-04-25 | Wisconsin Alumni Research Foundation | Using targeted radiotherapy (TRT) to drive anti-tumor immune response to immunotherapies |
| CN110418651A (zh) * | 2016-08-02 | 2019-11-05 | 哈佛学院院长等 | 用于调节免疫应答的生物材料 |
| FI3922279T3 (fi) * | 2016-08-30 | 2025-02-04 | Dana Farber Cancer Inst Inc | Lääkkeenantokoostumuksia ja niiden käyttötapoja |
| WO2018042411A1 (en) | 2016-09-04 | 2018-03-08 | Alex Levitzki Management And Holdings, Ltd. | Chimeric proteins for targeting dsrna |
| EP3321362A1 (en) * | 2016-11-10 | 2018-05-16 | Centre Leon Berard | Tlr3 agonist for use for inducing apoptosis in senescent cancer cells |
| WO2018183885A1 (en) * | 2017-03-31 | 2018-10-04 | Epizyme, Inc. | Combination therapy for treating cancer |
| MX2019011945A (es) * | 2017-04-05 | 2019-11-28 | Boehringer Ingelheim Int | Terapia de combinacion contra cancer. |
| SG11201910176PA (en) | 2017-05-11 | 2019-11-28 | Alpha Tau Medical Ltd | Polymer coatings for brachytherapy devices |
| JP2020520368A (ja) | 2017-05-17 | 2020-07-09 | ビオンコテック セラピューティクス エセ.エレ | 二本鎖ポリリボヌクレオチドとポリアルキレンイミンとの複合体を含む粒子を含む新規な医薬組成物 |
| EP3688008A1 (en) | 2017-09-27 | 2020-08-05 | TargImmune Therapeutics AG | Castration resistant prostate cancer |
| WO2019173456A1 (en) * | 2018-03-06 | 2019-09-12 | Board Of Regents, The University Of Texas System | Replication stress response biomarkers for immunotherapy response |
| WO2019170890A1 (en) | 2018-03-08 | 2019-09-12 | Targimmune Therapeutics Ag | A recombinant protein comprising a double stranded rna binding domain |
| CN116585625A (zh) | 2018-03-08 | 2023-08-15 | 阿尔法陶医疗有限公司 | 放射治疗籽源和施药器 |
| WO2019193464A1 (en) | 2018-04-02 | 2019-10-10 | Alpha Tau Medical Ltd. | Controlled release of radionuclides |
| EP3856256A1 (en) * | 2018-09-26 | 2021-08-04 | Ascendis Pharma A/S | Novel hydrogel conjugates |
| SG11202109274TA (en) | 2019-04-03 | 2021-10-28 | Targimmune Therapeutics Ag | Immunotherapy for the treatment of cancer |
| MX2022002753A (es) | 2019-10-10 | 2022-04-06 | Alpha Tau Medical Ltd | Preparacion humeda de fuentes de radioterapia. |
-
2019
- 2019-10-31 KR KR1020217013680A patent/KR20210087949A/ko not_active Ceased
- 2019-10-31 CN CN202311449613.9A patent/CN117338800A/zh active Pending
- 2019-10-31 AU AU2019370892A patent/AU2019370892B2/en active Active
- 2019-10-31 JP JP2021518633A patent/JP2022505022A/ja active Pending
- 2019-10-31 CA CA3114299A patent/CA3114299A1/en active Pending
- 2019-10-31 EP EP19879337.4A patent/EP3873598B1/en active Active
- 2019-10-31 HU HUE19879337A patent/HUE072799T2/hu unknown
- 2019-10-31 ES ES19879337T patent/ES3035872T3/es active Active
- 2019-10-31 SG SG11202102627PA patent/SG11202102627PA/en unknown
- 2019-10-31 HR HRP20250846TT patent/HRP20250846T1/hr unknown
- 2019-10-31 US US17/288,926 patent/US12594291B2/en active Active
- 2019-10-31 PL PL19879337.4T patent/PL3873598T3/pl unknown
- 2019-10-31 WO PCT/IB2019/059331 patent/WO2020089819A1/en not_active Ceased
- 2019-10-31 EP EP25179481.4A patent/EP4603098A3/en active Pending
- 2019-10-31 CN CN201980070966.3A patent/CN112912137B/zh active Active
-
2023
- 2023-07-26 AU AU2023208136A patent/AU2023208136B2/en active Active
-
2024
- 2024-10-04 JP JP2024174991A patent/JP2025013822A/ja active Pending
-
2025
- 2025-09-11 AU AU2025230719A patent/AU2025230719A1/en active Pending
-
2026
- 2026-03-05 US US19/557,204 patent/US20260191895A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Koka et al. | Technological advancements in external beam radiation therapy (EBRT): An indispensable tool for cancer treatment | |
| CY1120445T1 (el) | Συνδυασμοι και τροποι χορηγησης θεραπευτικων παραγοντων και θεραπεια συνδυασμου | |
| Bert et al. | Particle therapy for noncancer diseases | |
| WO2009008992A3 (en) | Combination anti-cancer therapy comprising an inhibitor of both mtorc1 and mt0rc2 | |
| JP2018502120A5 (cg-RX-API-DMAC7.html) | ||
| Srinivasan et al. | A comprehensive overview of radiation therapy impacts of various cancer treatments and pivotal role in the immune system | |
| JP2017515847A5 (cg-RX-API-DMAC7.html) | ||
| JP2020501589A5 (cg-RX-API-DMAC7.html) | ||
| JP2013523659A5 (cg-RX-API-DMAC7.html) | ||
| Dogan et al. | Automatic feathering of split fields for step-and-shoot intensity modulated radiation therapy | |
| US7963902B2 (en) | Computer prescribed treatment to reduced damage from radiation therapy and chemotherapy | |
| WO2018126280A1 (en) | Reducing damage from chemotherapy and increasing cancer kill rates by using interweaved low dose radiation | |
| Wittych et al. | Angiosarcoma of the scalp: a case report | |
| AU2017342086A1 (en) | Treatment of cholangiocarcinoma with TPCS-2a induced photochemical internalisation of gemcitabine | |
| Bush | Proton radiation therapy for lung cancer: is there enough evidence? | |
| Korbelik | World Journal of | |
| JP2010535084A5 (cg-RX-API-DMAC7.html) | ||
| Marcu | Radiation therapy fractionation in the modern era of head and neck oncology towards an improved therapeutic window | |
| Jamil et al. | Antibiotics: Past, present and future | |
| Takaoka | Proton Beam Therapy on Pediatric Cancer: A Review. | |
| Alva-Sánchez et al. | Preliminary Monte Carlo simulation of non-laser light sources for photodynamic therapy | |
| RU2008137226A (ru) | Способ и композиция для защиты от радиации | |
| Trapeznikov et al. | Treatment of limb osteosarcoma at the turn of the century (half century of experience in research) | |
| Al-Yasiri et al. | Proton Therapy: Technique of the Future to Treat Cancer Patients | |
| Ballari et al. | Toxicity Outcome Using Bladder-Rectum Spacer Balloon Versus Vaginal Gauze Packing in Brachytherapy in Cervical Cancer. |